A series of immune checkpoints, including CTLA-4, PD-1, PD-L1, and lymphocyte activation gene 3 (LAG-3), have been confirmed to be involved in the induction and maintenance of immune tolerance in HCC [30–32]. This evidence concerns the gene LAG3 and hepatocellular carcinoma.